EN DE
Watch Standard Dental Labs Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Standard Dental Labs Inc (TUTH) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Standard Dental Labs Inc stock $0.07, price $0.08, that is 15.1% below the price, quality 46 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US

SD Standard Dental Labs Inc logo Thin data Nov 10, 2026

Standard Dental Labs Inc

TUTH · US
Weak valuation

Our calculation puts a fair price 15% below what the stock costs today.

Quality 46/100
Mixed Growth (revenue 3y +10.9 %/yr in USD)
Negative equity (buybacks among others)
Fair value $0.0678 · Overvalued
Negative free cash flow
Trails peers (1/5)
Narrow moat 12/100 · thin data
Thin data
Estimate
Watch Standard Dental Labs Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$8.57 $0.0202 Fair Value $0.0678 Nov 2017 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range $0.0202 – $8.57 · fair‑value band $0.0548 – $0.0807 · the $0.0798 price screens above the $0.0678 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Standard Dental Labs in your weekly email

Every Wednesday you see whether Standard Dental Labs is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Standard Dental Labs Inc., a dental laboratory company, manufactures dental products in Florida. It offers dental implants, crowns, bridges, veneers, and dentures. The company was incorporated in 1998 and is based in Orlando, Florida.

Stock analysis

Standard Dental Labs Inc (TUTH) currently trades at $0.0798, while our estimate is $0.0678, 15% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: $0.0548 (bear) to $0.0807 (bull), the price of $0.0798 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 46/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Standard Dental Labs Inc reported revenue of $236K in FY2025 versus $53.7K in FY2015, a compound +16.0%/yr. Reported net income was −$1.1M in FY2025.

Key figures

Market cap $3.0M Micro · P/S ratio 6.21 · Return on assets (EBIT) −563% (4-year average) · Operating margin −93.0% · Revenue (TTM) $416K · Revenue growth (YoY) +196% · Free cash flow −$194K · Net debt $2.3M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (low confidence).

What moves the price

The share trades about 88% below its 52-week high and 100% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at −15%, TUTH screens cheaper than that median.

Fair Value

Bear $0.0548 Fair Value $0.0678 Bull $0.0807
Price $0.0798 · Downside -15.1%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 46/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 50
How much profit the company makes from its sales and capital
Quality Growth 4
Are margins and returns getting better?
Cashflow 25
Do the profits arrive as real cash?
Financial strength 28
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 3
Distance to the 52-week high, does not count
New shares 100
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 23/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−16.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.9%
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+27.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−29.7% (2013) → −365.5% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

TUTH screens overvalued: fair value 15% below the price. Compare with Intuitive Surgical, Inc →

Compare Standard Dental Labs Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 196 stocks

Beats the industry median on 1/5 measures
Overall it trails its industry peers.
Valuation
Quality Score 46 · Below median
Fair Value upside −15.0% · Below median
Profitability
Return on equity (12 months) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Operating margin (12 months) −93.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 196.3% · Top 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months) 7.16× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)13 · sector 21
FUTURE (revenue growth)100 · sector 40
PAST (return on equity)0 · sector 26
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 32

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Solventum Corporation SOLV $90.08 $131.27 +46% vs TUTH
EssilorLuxottica Société anonyme EL €187.60 €196.22 +5% vs TUTH
Intuitive Surgical, Inc ISRG $450.04 $353.90 −21% vs TUTH
Medline Inc MDLN $40.91 $28.59 −30% vs TUTH
Alcon Inc ALC CHF 61.88 CHF 34.06 −45% vs TUTH
Becton, Dickinson and Company BDX $212.61 $97.80 −54% vs TUTH
Straumann Holding STMN CHF 106.85 CHF 45.50 −57% vs TUTH
West Pharmaceutical Services, Inc WST $412.55 $139.22 −66% vs TUTH
Sartorius Stedim Biotech S.A DIM €223.40 €54.82 −75% vs TUTH
Sartorius Aktiengesellschaft SRT €227.00 €42.50 −81% vs TUTH

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Standard Dental Labs Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Standard Dental Labs Inc Fair Value". https://www.fairvalue-calculator.com/stock/TUTH

Frequently asked questions

Is Standard Dental Labs Inc (TUTH) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is $0.0678 versus a price of $0.0798, about 15% lower (overvalued).
What is the fair value of TUTH?
Our estimate for Standard Dental Labs Inc is $0.0678 (as of Nov 10, 2026), built from audited fundamentals. The current price: $0.0798.
What is the quality score of TUTH?
Standard Dental Labs Inc has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Standard Dental Labs Inc (TUTH)?
Our calculated price target is the estimate of $0.0678 (as of Nov 10, 2026). Cautious scenario $0.0548, optimistic scenario $0.0807. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Standard Dental Labs Inc stock forecast for 2026?
Our estimate puts fair value at $0.0678, about 15% lower versus a price of $0.0798 (overvalued). Cautious scenario $0.0548, optimistic scenario $0.0807. The calculation is refreshed regularly with new filings.
What is the revenue of Standard Dental Labs Inc (TUTH)?
Standard Dental Labs Inc reported trailing-twelve-month revenue of about $416K (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Standard Dental Labs Inc (TUTH)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Standard Dental Labs Inc it is $0.0678 per share (as of Nov 10, 2026), against a price of $0.0798.
Is Standard Dental Labs Inc stock overvalued or undervalued in 2026?
As of Nov 10, 2026, TUTH trades above its calculated fair value: price $0.0798, fair value $0.0678, a gap of about −15% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of TUTH?
No. The price is what the market pays today ($0.0798); the fair value is what the company's own numbers justify ($0.0678). For Standard Dental Labs Inc the two are $0.0121 per share apart. That gap is exactly why we show both numbers side by side.
How much is Standard Dental Labs Inc worth?
The market values Standard Dental Labs Inc at about $3.0M (market capitalisation, as of Nov 10, 2026). Per share that is $0.0798; our models calculate a fair value of $0.0678 per share.
What do the bullish and bearish scenarios say about TUTH?
Our models span a range for Standard Dental Labs Inc: cautious scenario $0.0548, base $0.0678, optimistic $0.0807 per share (as of Nov 10, 2026, price $0.0798). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Standard Dental Labs Inc (TUTH)?
Balance-sheet figures for Standard Dental Labs Inc (as of Nov 10, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is TUTH from its 52-week high?
Standard Dental Labs Inc trades at $0.0798, about 88% below its 52-week high of $0.6700 and 100% above the low of $0.0400 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0678 is for.
Which stocks are comparable to Standard Dental Labs Inc?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Standard Dental Labs Inc stock attractive at the current price?
The data as of Nov 10, 2026: price $0.0798, calculated fair value $0.0678 (−15%), Quality Score 46/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Standard Dental Labs Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Standard Dental Labs Inc (TUTH)?
The closing price on Nov 6, 2026 was $0.0798. Our estimate is $0.0678, about 15% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Standard Dental Labs Inc right now?
Weak quality (46/100) and above fair value at the same time, the margin of safety is missing on both counts. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Standard Dental Labs Inc

How large is the market capitalisation of Standard Dental Labs Inc (TUTH)?
The market capitalisation of Standard Dental Labs Inc is $3.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Standard Dental Labs Inc (TUTH)?
The price-to-sales ratio of Standard Dental Labs Inc is 6.21 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the EBIT return on assets of Standard Dental Labs Inc (TUTH)?
On an EBIT basis the return on assets of Standard Dental Labs Inc is −563% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Standard Dental Labs Inc (TUTH)?
The operating margin of Standard Dental Labs Inc is −93.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Standard Dental Labs Inc (TUTH)?
Revenue at Standard Dental Labs Inc is growing +196% versus a year earlier (3y avg +10.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Standard Dental Labs Inc (TUTH) generate?
The free cash flow of Standard Dental Labs Inc is −$194K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Standard Dental Labs Inc (TUTH) carry?
The net debt of Standard Dental Labs Inc is $2.3M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Standard Dental Labs Inc in the live analysis

One click puts Standard Dental Labs Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.